Limited generalizability and high risk of bias in multivariable models predicting conversion risk from mild cognitive

Robin Jeanna Vermeulen1, Vebjørn Andersson2, Jimmy Banken1

  • 1Department of Medical Imaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Insights

Numerous prediction models exist to identify mild cognitive impairment (MCI) cases likely to progress to dementia. However, most models lack external validation and have a high risk of bias, limiting their clinical applicability.

Area of Science:

  • Neuroscience
  • Gerontology
  • Medical Informatics

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • Accurate prediction of MCI to dementia conversion is crucial for timely intervention and management.
  • Existing prediction models vary in their development, validation, and data sources.

Purpose of the Study:

  • To systematically review and summarize multi-source prediction models for MCI to dementia conversion.
  • To assess the predictors, performance, risk of bias, and generalizability of these models.
  • To identify gaps and provide recommendations for future research in MCI prediction.

Main Methods:

  • Systematic literature search of PubMed and Embase databases up to January 18, 2024.
  • Inclusion of model development and validation studies for MCI to dementia conversion.
  • Assessment of models based on predictors, predictive performance (e.g., AUC, accuracy), risk of bias, and generalizability.

Main Results:

  • 62 studies were included, comprising 41 machine learning, 11 regression models, and 5 disease state indexes.
  • Common predictors included magnetic resonance imaging (MRI) and cognitive scores; models used 2 to 60 predictors.
  • Models demonstrated reasonable predictive capabilities (AUC: 0.58-0.98, accuracy: 66.1-96.3%), but most studies had high risk of bias and lacked external validation (47 studies).

Conclusions:

  • No current prediction model for MCI to dementia conversion is highly valid due to limited generalizability and high risk of bias.
  • While models show promising performance, significant limitations in external validation and generalizability persist.
  • Future efforts must prioritize external validation, generalizability, and clinical applicability for robust MCI to dementia prediction models.

Related Concept Videos

Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
106
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
117
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
106
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
72
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
99
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
12.6K